Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Teillac · SciRah

Researcher profile · Semantic Scholar

P. Teillac

Share profile

P. Teillac — researcher profile on SciRah

h-index: 26
Works: 135
Citations: 3,184

Most-cited papers

Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43.
P. Berthon, A. Valeri, A. Cohen-Akenine, E. Drelon +21 more
1998American Journal of Human Genetics351 citations Open access
Semantic Scholar
Comparison of phytotherapy (Permixon®) with finasteride in the treatment of benign prostate hyperplasia: A randomized international study of 1,098 patients
J. Carraro, J. Raynaud, G. Koch, G. Chisholm +12 more
1996The Prostate339 citations
Semantic Scholar
Benign prostatic hyperplasia: a progressive disease of aging men.
M. Emberton, G. Andriole, J. de la Rosette, B. Djavan +8 more
2003Urology214 citations
Semantic Scholar
[Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study].
F. Debruyne, G. Koch, P. Boyle, F. D. da Silva +6 more
2002Progrès en urologie (Paris)209 citations
Semantic Scholar
Impact of symptoms of prostatism on level of bother and quality of life of men in the French community.
P. Sagnier, G. Macfarlane, P. Teillac, H. Botto +2 more
1995Journal of Urology148 citations
Semantic Scholar
Management of prostate‐specific antigen relapse in prostate cancer: A European consensus
L. Boccon-Gibod, B. Djavan, P. Hammerer, W. Hoeltl +4 more
2004International journal of clinical practice136 citations Open access
Semantic Scholar
Plasma neuroendocrine markers in patients with benign prostatic hyperplasia and prostatic carcinoma.
O. Cussenot, J. Villette, A. Valéri, G. Cariou +6 more
1996Journal of Urology103 citations
Semantic Scholar
Assessment of microsatellite instability in urine in the detection of transitional‐cell carcinoma of the bladder
S. Mourah, O. Cussenot, V. Vimont, F. Desgrandchamps +5 more
1998International Journal of Cancer82 citations Open access
Semantic Scholar
Evaluation of male sexual function in patients with Lower Urinary Tract Symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon), Tamsulosin or Finasteride.
A. Zlotta, P. Teillac, J. Raynaud, C. Schulman
2005European Urology76 citations
Semantic Scholar
Characteristics of patients presenting with LUTS/BPH in six European countries.
A. Hutchison, R. Farmer, C. Chapple, R. Berges +4 more
2006European Urology68 citations
Semantic Scholar
Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysis.
F. Debruyne, P. Boyle, F. M. Calais da Silva, Jay G. Gillenwater +6 more
2004European Urology65 citations
Semantic Scholar
Abarelix: the first gonadotrophin-releasing hormone antagonist for the treatment of prostate cancer
P. Mongiat-Artus, P. Teillac
2004Expert Opinion on Pharmacotherapy56 citations
Semantic Scholar
Non‐invasive molecular detection of bladder cancer recurrence
Najla Amira, S. Mourah, F. Rozet, P. Teillac +7 more
2002International Journal of Cancer50 citations Open access
Semantic Scholar
Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives
A. Valéri, G. Fournier, V. Morin, J. Morin +5 more
2000International Journal of Cancer50 citations Open access
Semantic Scholar
Urinary flow rates in patients with benign prostatic hypertrophy following treatment with alfuzosin. DUALF Group.
P. Teillac, M. Delauche-Cavallier, P. Attali
1992British Journal of Urology50 citations
Semantic Scholar
Argon laser induced autofluorescence may distinguish between normal and tumor human urothelial cells: a microspectrofluorimetric study.
M. Anidjar, O. Cussenot, J. Blais, O. Bourdon +6 more
1996Journal of Urology49 citations
Semantic Scholar
In vivo model mimicking natural history of dog prostate cancer using DPC‐1, a new canine prostate carcinoma cell line
M. Anidjar, J. Villette, P. Devauchelle, F. Delisle +11 more
2001The Prostate44 citations
Semantic Scholar
Subcutaneous Pyelovesical Bypass As Replacement for Standard Percutaneous Nephrostomy for Palliative Urinary Diversion: Prospective Evaluation of Patient's Quality of Life
F. Desgrandchamps, S. Leroux, V. Ravery, G. Bochereau +4 more
2007Journal of endourology41 citations
Semantic Scholar
The Role of Laser‐Induced Autofluorescence Spectroscopy in Bladder Tumor Detection: Dependence on the Excitation Wavelength
M. Anidjar, O. Cussenot, S. Avrillier, D. Ettori +2 more
1998Annals of the New York Academy of Sciences35 citations
Semantic Scholar
Anatomical bases of percutaneous surgery for calculi in horseshoe kidney
O. Cussenot, F. Desgrandchamps, P. Ollier, P. Teillac +1 more
2005Surgical and Radiologic Anatomy28 citations
Semantic Scholar
VEGF and VEGFR‐1 are coexpressed by epithelial and stromal cells of renal cell carcinoma
J. Rivet, S. Mourah, H. Murata, N. Mounier +6 more
2008Cancer27 citations Open access
Semantic Scholar
Chemotherapeutic prevention studies of prostate cancer.
B. Djavan, A. Zlotta, C. Schulman, P. Teillac +4 more
2004Journal of Urology27 citations
Semantic Scholar
The clinical implications of the Prostate Cancer Prevention Trial
M. Marberger, J. Adolfsson, A. Borkowski, J. Fitzpatrick +5 more
2003BJU International27 citations
Semantic Scholar
Renal hemodynamic and functional effect of PEEP ventilation in human renal transplantations.
L. Jacob, J. Chazalet, D. Payen, S. Villiers +5 more
1995American Journal of Respiratory and Critical Care Medicine27 citations
Semantic Scholar
Spectrum of molecular alterations in colorectal, upper urinary tract, endocervical, and renal carcinomas arising in a patient with hereditary non-polyposis colorectal cancer
P. Mongiat-Artus, C. Miquel, J. Fléjou, F. Coulet +5 more
2006Virchows Archiv26 citations
Semantic Scholar
Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.
F. Debruyne, G. Koch, P. Boyle, F. D. da Silva +6 more
2002European Urology26 citations
Semantic Scholar
Pharmacodynamic Equivalence of a Decapeptyl 3-Month SR Formulation with the 28-Day SR Formulation in Patients with Advanced Prostate Cancer
P. Teillac, C. Heyns, A. Kaisary, O. Bouchot +1 more
2004Hormone Research in Paediatrics24 citations
Semantic Scholar
Laparoscopic Fibrin Glue Ureteral Anastomosis: Experimental Study in the Porcine Model
M. Anidjar, F. Desgrandchamps, L. Martin, B. Cochand-Priollet +3 more
1996Journal of endourology22 citations
Semantic Scholar
Infrequent microsatellite instability in urothelial cell carcinoma of the bladder in young patients.
P. Mongiat-Artus, C. Miquel, M. V. D. van der Aa, O. Buhard +5 more
2006European Urology19 citations
Semantic Scholar
[Evaluation of the clinical benefit of Permixon and tamsulosin in severe BPH patients--PERMAL study subset analysis].
F. Debruyne, P. Boyle, R. Vela-Navarrete, F. D. da Silva +4 more
2004Progrès en urologie (Paris)19 citations
Semantic Scholar
Expert opinion on 6‐monthly luteinizing hormone‐releasing hormone agonist treatment with a novel depot delivery system for prostate cancer
C. Schulman, A. Alcaraz, R. Berges, F. Montorsi +2 more
2007BJU International18 citations
Semantic Scholar
[Benign prostatic hyperplasia: patients' perception of medical treatment and their expectations. Results of a french survey involving patients treated with finasteride].
P. Teillac
2002The´rapie (Paris)18 citations
Semantic Scholar
Total ureteral replacement by subcutaneous pyelovesical bypass in ureteral necrosis after renal transplantation
F. Desgrandchamps, A. Duboust, P. Teillac, J. Idatte +1 more
1998Transplant International17 citations Open access
Semantic Scholar
New Trends in Bladder Cancer Management
J. Irani, N. Mottet, M. Caparrós, P. Teillac
200716 citations
Semantic Scholar
The Prostate Cancer Prevention Trial and Its Implications for Clinical Practice: A European Consensus
P. Teillac, P. Abrahamsson
200616 citations
Semantic Scholar
Relief of BPO or Improvement in Quality of Life?
P. Teillac
1998European Urology16 citations
Semantic Scholar
Role of Luteinising Hormone Releasing Hormone (LHRH) Agonists and Hormonal Treatment in the Management of Prostate Cancer
P. Mongiat-Artus, P. Teillac
200514 citations
Semantic Scholar
A New Prostatic Stent for the Treatment of Benign Prostatic Hyperplasia in High–Risk Patients
O. Traxer, M. Anidjar, F. Gaudez, F. Saporta +6 more
2000European Urology14 citations
Semantic Scholar
[Results of the surgical treatment of benign hypertrophy of the prostate].
R. Fourcade, Y. Lanson, P. Teillac
1993Progrès en urologie (Paris)14 citations
Semantic Scholar
Bladder Cancer: Management and Future Directions
C. Evans, F. Debruyne, H. Payne, E. Solsona +2 more
200713 citations
Semantic Scholar
Economic Issues in the Treatment of BPH
P. Teillac, R. Scarpa
200612 citations
Semantic Scholar
[Value of a visual analogue scale for evaluation of the severity of symptoms of benign prostatic hyperplasia (BPH). Pilot study in two urology centres].
P. Teillac, F. Rozet, N. Terrier, P. Mongiat-Artus +1 more
2004Progrès en urologie (Paris)11 citations
Semantic Scholar
The role of growth factors in the pathogenesis of benign prostatic hyperplasia
F. Desgrandchamps, P. Teillac
199410 citations
Semantic Scholar
A critical analysis of Permixon™ in the treatment of lower urinary tract symptoms due to benign prostatic enlargement
C. Maccagnano, A. Salonia, A. Briganti, P. Teillac +3 more
20069 citations
Semantic Scholar
Hormone Therapy for Prostate Cancer: Guidelines versus Clinical Practice
A. Alcaraz, P. Teillac
20068 citations
Semantic Scholar
349 Evaluation of the clinical benefit of Permixon and Tamsulosin in severe BPH patients. Permal study sub-set analysis
F. Debruyne, P. Boyle, Remigio Vela Navarrete, F. D. da Silva +4 more
20048 citations
Semantic Scholar
[Genetic aspects in cancers of the prostate].
O. Cussenot, A. Valéri, P. Meria, P. Berthon +4 more
1996Pathologie et biologie8 citations
Semantic Scholar
Endoscopic Surveillance of Self-Expandable Metal Prostheses in Recurrent Urethral Strictures
A. Schaetz, A. le Duc, P. Teillac, O. Cussenot +2 more
19927 citations
Semantic Scholar
Evaluation of transurethral anhydrous alcohol injection for symptomatic benign prostatic hyperplasia (BPH) — An european multi-center experience
M. Plante, V. Baena, P. Ballanger, J. Castinieras +14 more
20036 citations
Semantic Scholar
BPH: a progressive disease of the ageing male
M. Emberton, G. Andriole, J. Rosette, B. Djavan +8 more
20026 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

O. Cussenot×11
Invite
O. Cussenot — researcher profile on SciRah
A. le Duc×10
Invite
A. le Duc — researcher profile on SciRah
F. Desgrandchamps×9
Invite
F. Desgrandchamps — researcher profile on SciRah
C. Schulman×7
Invite
C. Schulman — researcher profile on SciRah

×6

Invite

J. Raynaud — researcher profile on SciRah

Invite

F. Hamdy — researcher profile on SciRah

Invite

P. Perrin — researcher profile on SciRah

P. Mongiat-Artus×6

Invite

P. Mongiat-Artus — researcher profile on SciRah

F. D. da Silva×5

Invite

F. D. da Silva — researcher profile on SciRah

Invite

P. Boyle — researcher profile on SciRah

Invite

J. Fiet — researcher profile on SciRah

Invite

M. Anidjar — researcher profile on SciRah